Mutation of senataxin alters disease-specific transcriptional networks in patients with ataxia with oculomotor apraxia type 2.

Senataxin, encoded by the SETX gene, contributes to multiple aspects of gene expression, including transcription and RNA processing. Mutations in SETX cause the recessive disorder ataxia with oculomotor apraxia type 2 (AOA2) and a dominant juvenile form of amyotrophic lateral sclerosis (ALS4). To assess the functional role of senataxin in disease, we examined differential gene expression in AOA2 patient fibroblasts, identifying a core set of genes showing altered expression by microarray and RNA-sequencing. To determine whether AOA2 and ALS4 mutations differentially affect gene expression, we overexpressed disease-specific SETX mutations in senataxin-haploinsufficient fibroblasts and observed changes in distinct sets of genes. This implicates mutation-specific alterations of senataxin function in disease pathogenesis and provides a novel example of allelic neurogenetic disorders with differing gene expression profiles. Weighted gene co-expression network analysis (WGCNA) demonstrated these senataxin-associated genes to be involved in both mutation-specific and shared functional gene networks. To assess this in vivo, we performed gene expression analysis on peripheral blood from members of 12 different AOA2 families and identified an AOA2-specific transcriptional signature. WGCNA identified two gene modules highly enriched for this transcriptional signature in the peripheral blood of all AOA2 patients studied. These modules were disease-specific and preserved in patient fibroblasts and in the cerebellum of Setx knockout mice demonstrating conservation across species and cell types, including neurons. These results identify novel genes and cellular pathways related to senataxin function in normal and disease states, and implicate alterations in gene expression as underlying the phenotypic differences between AOA2 and ALS4.

[1]  Lorne Zinman,et al.  Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis , 2014, Nature Neuroscience.

[2]  V. Shakkottai,et al.  Clinical neurogenetics: autosomal dominant spinocerebellar ataxia. , 2013, Neurologic clinics.

[3]  J. Manley,et al.  A SUMO-dependent interaction between Senataxin and the exosome, disrupted in the neurodegenerative disease AOA2, targets the exosome to sites of transcription-induced DNA damage , 2013, Genes & development.

[4]  Hao Chen,et al.  Functional inactivation of orexin 1 receptors in the cerebellum disrupts trace eyeblink conditioning and local theta oscillations in guinea pigs , 2013, Behavioural Brain Research.

[5]  K. Mckinney,et al.  Senataxin Plays an Essential Role with DNA Damage Response Proteins in Meiotic Recombination and Gene Silencing , 2013, PLoS genetics.

[6]  M. Takagi,et al.  Ataxia telangiectasia mutated‐dependent regulation of topoisomerase II alpha expression and sensitivity to topoisomerase II inhibitor , 2013, Cancer science.

[7]  A. Ludolph,et al.  The SETX missense variation spectrum as evaluated in patients with ALS4-like motor neuron diseases , 2013, neurogenetics.

[8]  S. West,et al.  Senataxin, Defective in the Neurodegenerative Disorder Ataxia with Oculomotor Apraxia 2, Lies at the Interface of Transcription and the DNA Damage Response , 2012, Molecular and Cellular Biology.

[9]  B. Berkhout,et al.  Microprocessor, Setx, Xrn2, and Rrp6 Co-operate to Induce Premature Termination of Transcription by RNAPII , 2012, Cell.

[10]  C. Weitz,et al.  Feedback Regulation of Transcriptional Termination by the Mammalian Circadian Clock PERIOD Complex , 2012, Science.

[11]  D. Geschwind,et al.  Genomic medicine enters the neurology clinic , 2012, Neurology.

[12]  B. Fogel.  Childhood Cerebellar Ataxia , 2012, Journal of child neurology.

[13]  Neelroop Parikshak,et al.  RBFOX1 regulates both splicing and transcriptional networks in human neuronal development. , 2012, Human molecular genetics.

[14]  D. Geschwind,et al.  Mutations in rare ataxia genes are uncommon causes of sporadic cerebellar ataxia , 2012, Movement disorders : official journal of the Movement Disorder Society.

[15]  K. Zerres,et al.  SETX gene mutation in a family diagnosed autosomal dominant proximal spinal muscular atrophy , 2012, Neuromuscular Disorders.

[16]  F. Santorelli,et al.  Motor chip: a comparative genomic hybridization microarray for copy-number mutations in 245 neuromuscular disorders. , 2011, Clinical chemistry.

[17]  D. Geschwind,et al.  A gene expression phenotype in lymphocytes from friedreich ataxia patients , 2011, Annals of neurology.

[18]  K. Davies,et al.  Oxr1 Is Essential for Protection against Oxidative Stress-Induced Neurodegeneration , 2011, PLoS genetics.

[19]  E. Halperin,et al.  Matrin 3 Binds and Stabilizes mRNA , 2011, PloS one.

[20]  Konstantina Skourti-Stathaki,et al.  Human Senataxin Resolves RNA/DNA Hybrids Formed at Transcriptional Pause Sites to Promote Xrn2-Dependent Termination , 2011, Molecular cell.

[21]  S. Horvath,et al.  Transcriptomic Analysis of Autistic Brain Reveals Convergent Molecular Pathology , 2011, Nature.

[22]  Brent L Fogel.  Interpretation of genetic testing: variants of unknown significance. , 2011, Continuum.

[23]  S. Perlman,et al.  Uncommon Causes of Movement Disorders: Cerebellar disorders , 2011 .

[24]  Uncommon Causes of Movement Disorders: Frontmatter , 2011 .

[25]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[26]  W. Huber,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .

[27]  M. Culbertson,et al.  Sen1p Performs Two Genetically Separable Functions in Transcription and Processing of U5 Small Nuclear RNA in Saccharomyces cerevisiae , 2010, Genetics.

[28]  N. Drouot,et al.  Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients. , 2009, Brain : a journal of neurology.

[29]  M. Lavin,et al.  Functional role for senataxin, defective in ataxia oculomotor apraxia type 2, in transcriptional regulation. , 2009, Human molecular genetics.

[30]  M. Minnerop,et al.  Exon deletions and intragenic insertions are not rare in ataxia with oculomotor apraxia 2 , 2009, BMC Medical Genetics.

[31]  S. Perlman,et al.  Aberrant Splicing of the Senataxin Gene in a Patient with Ataxia with Oculomotor Apraxia Type 2 , 2009, The Cerebellum.

[32]  Steve Horvath,et al.  Molecular Systems Biology 5; Article number 291; doi:10.1038/msb.2009.46 Citation: Molecular Systems Biology 5:291 , 2022 .

[33]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[34]  S. Horvath,et al.  Functional organization of the transcriptome in human brain , 2008, Nature Neuroscience.

[35]  B. Brais,et al.  Ataxia-oculomotor apraxia 2 patients show no increased sensitivity to ionizing radiation , 2007, Neuromuscular Disorders.

[36]  Stephen T Warren,et al.  Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. , 2007, Human molecular genetics.

[37]  M. Gatei,et al.  Senataxin, defective in ataxia oculomotor apraxia type 2, is involved in the defense against oxidative DNA damage , 2007, The Journal of cell biology.

[38]  Brent L Fogel,et al.  Clinical features and molecular genetics of autosomal recessive cerebellar ataxias , 2007, The Lancet Neurology.

[39]  S. Perlman,et al.  Novel mutations in the senataxin DNA/RNA helicase domain in ataxia with oculomotor apraxia 2 , 2006, Neurology.

[40]  I. Glass,et al.  Senataxin, the yeast Sen1p orthologue: Characterization of a unique protein in which recessive mutations cause ataxia and dominant mutations cause motor neuron disease , 2006, Neurobiology of Disease.

[41]  F. Pierelli,et al.  Ataxia with oculomotor apraxia type 2 , 2006, Neurology.

[42]  Y. Z. Chen,et al.  In cis autosomal dominant mutation of Senataxin associated with tremor/ataxia syndrome , 2006, Neurogenetics.

[43]  S. Horvath,et al.  A General Framework for Weighted Gene Co-Expression Network Analysis , 2005, Statistical applications in genetics and molecular biology.

[44]  D. Labuda,et al.  Mutations in senataxin responsible for Quebec cluster of ataxia with neuropathy , 2005, Annals of neurology.

[45]  John W Griffin,et al.  DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). , 2004, American journal of human genetics.

[46]  M. Culbertson,et al.  Multiple protein/protein and protein/RNA interactions suggest roles for yeast DNA/RNA helicase Sen1p in transcription, transcription-coupled DNA repair and RNA processing. , 2004, Nucleic acids research.

[47]  S. Keleş,et al.  Statistical Applications in Genetics and Molecular Biology Asymptotic Optimality of Likelihood-Based Cross-Validation , 2011 .

[48]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[49]  J. Schulz,et al.  Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2 , 2004, Nature Genetics.

[50]  M. Rosenfeld,et al.  The MAZ protein is an autoantigen of Hodgkin's disease and paraneoplastic cerebellar dysfunction , 2003, Annals of neurology.

[51]  A. Olsen,et al.  The pregnancy-specific glycoprotein (PSG) gene cluster on human chromosome 19: fine structure of the 11 PSG genes and identification of 6 new genes forming a third subgroup within the carcinoembryonic antigen (CEA) family. , 1994, Genomics.